CYP17 gene promoter allelic variant is not associated with prostate cancer
Authors:
- 1 July 2003
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 21 (4) , 262-265
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- EAU Guidelines on Prostate CancerEuropean Urology, 2001
- A polymorphism in theCYP17 gene is associated with prostate cancer riskInternational Journal of Cancer, 2000
- Association betweenCYP17 gene polymorphism and risk of breast cancer in young womenInternational Journal of Cancer, 1999
- Polymorphism T→C (−34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndromeFertility and Sterility, 1999
- Early steps in androgen biosynthesis: From cholesterol to DHEABailliere's Clinical Endocrinology and Metabolism, 1998
- Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17Human Molecular Genetics, 1994
- Genes Involved in Androgen Biosynthesis and the Male PhenotypeHormone Research, 1992
- Systemic treatment for prostate cancerThe American Journal of Medicine, 1987
- Cloning and Sequence of the Human Gene for P450cl7 (Steroid 17α-Hydroxylase/17,20 Lyase): Similarity with the Gene for P450c21DNA, 1987
- Androgen‐dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaPThe Prostate, 1986